In addition, using the GDS4109 dataset, recurrent prostate cancer showed lower SSTR2 expression compared to non-recurrent cancers (386.5±140.5 [non-recurrent] vs. 340.2±137.0 [recurrent], p = 0.0438, Figure 3E). This evidence concerns the gene SSTR2 and cancer.